Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018

David Nierengarten Maintained (ANAB) at Buy with Increased Target to $151 on, Feb 20th, 2018

David Nierengarten of Wedbush, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Increased Target from $142 to $151 on, Feb 20th, 2018.

David has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Yatin Suneja of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $115 on, Wednesday, November 15th, 2017
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $101 on, Thursday, November 9th, 2017